Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,292Revenue $M115Net Margin (%)-43.9Z-Score57.1
Enterprise Value $M3,020EPS $-0.3Operating Margin %-40.3F-Score6
P/E(ttm))0Cash Flow Per Share $-0.5Pre-tax Margin (%)-43.8Higher ROA y-yY
Price/Book12.010-y EBITDA Growth Rate %-11.3Quick Ratio9.4Cash flow > EarningsY
Price/Sales23.95-y EBITDA Growth Rate %-1.4Current Ratio9.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-39.0Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-63.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M172ROI % (ttm)-84.5Gross Margin Increase y-yY

Gurus Latest Trades with AVNR

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AVNRLeon Cooperman 2014-09-30 Buy 0.02%$5.18 - $12.49
($6.76)
$ 16.99151%New holding, 100000 sh.100,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AVNR is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
AVNR Leon Cooperman 2014-09-30100,0000.060.02New Buy
Premium Most recent portfolio changes are included for Premium Members only!


AVNR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Katkin KeithPresident and CEO 2014-12-17Sell277,680$16.95-0.18view
PALEKAR ROHANSVP & Chief Commercial Officer 2014-11-28Sell15,000$1512.8view
Siffert Joao MDSVP, R&D 2014-10-24Sell8,426$11.843.39view
OCAMPO CHRISTINEVice President, Finance 2014-10-24Sell2,080$11.8143.27view
Katkin KeithPresident and CEO 2014-10-24Sell27,567$11.7643.88view
OCAMPO CHRISTINEVice President, Finance 2014-09-15Sell55,000$9.4579.05view
PALEKAR ROHANSVP & Chief Commercial Officer 2014-09-15Sell25,000$11.547.13view
OCAMPO CHRISTINEVice President, Finance 2014-08-26Sell2,110$6.1177.38view
Katkin KeithPresident and CEO 2014-08-01Sell9,670$5.26221.67view
Katkin KeithPresident and CEO 2014-05-28Sell442,212$5.01237.72view

Press Releases about AVNR :

Quarterly/Annual Reports about AVNR:

News about AVNR:

Articles On GuruFocus.com
Weekly CEO Sells Highlight: Danaher Corporation, Orbitz Worldwide Inc., 3D Systems Corporation and A May 20 2013 
Weekly CEO Sells Highlight: Universal Insurance Holdings Inc, Avanir Pharmaceuticals Inc, Bel Fuse I Jun 30 2012 
Options V: Short-Term Strategy – Earning Money on Volatility Oct 19 2011 
Avanir Pharmaceuticals Reports Operating Results (10-Q) Feb 07 2011 
Avanir Pharmaceuticals Reports Operating Results (10-K) Dec 08 2010 
Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 195,300 Shares Dec 03 2010 
Weekly CEO Sells Highlights: MAC, GNET, ASIA, and AVNR Sep 05 2010 
Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 102,874 Shares Sep 02 2010 
Avanir Pharmaceuticals Reports Operating Results (10-Q) Aug 05 2010 
Avanir Pharmaceuticals (AVNR) President and CEO Keith Katkin sells 105,906 Shares May 04 2010 

More From Other Websites
AVANIR PHARMACEUTICALS, INC. Financials Dec 17 2014
Otsuka Pharmaceutical Commences Tender Offer to Acquire All Outstanding Shares of Avanir... Dec 12 2014
10-K for Avanir Pharmaceuticals, Inc. Dec 12 2014
Morgan & Morgan Announces That Class Action Lawsuits Have Been Filed in Connection With the Sale of... Dec 11 2014
Avanir reports 4Q loss Dec 10 2014
Avanir reports 4Q loss Dec 10 2014
AVANIR PHARMACEUTICALS, INC. Files SEC form 10-K, Annual Report Dec 10 2014
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA) Dec 09 2014
Through Laughter and Tears Comes First-Ever Documentary about Life with PseudoBulbar Affect (PBA) Dec 09 2014
Law Offices of Marc S. Henzel Announces Securities Class Action Periods Dec 08 2014
The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, Cypress Semiconductor, Spansion and... Dec 08 2014
Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call Dec 05 2014
Avanir Pharmaceuticals Cancels Previously Scheduled Earnings Call Dec 05 2014
Lifshitz & Miller Law Firm Announces Investigation of Avanir Pharmaceuticals, Inc., Carbonite, Inc.,... Dec 04 2014
AVNR INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of... Dec 04 2014
AVANIR PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of... Dec 04 2014
Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Avanir Pharmaceuticals, Inc.... Dec 04 2014
Avanir Pharmaceuticals Inc. Stockholders Encouraged to Contact Securities Law Firm about Takeover Dec 04 2014
SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Avanir... Dec 03 2014
AVANIR PHARMACEUTICALS SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Avanir... Dec 03 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK